Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A randomized, double-blind, placebo- and active-controlled, parallel group, 6-week study to evaluate the effect of multiple doses of Flutiform [formoterol/fluticasone propionate] 250/10 microgram HFA [hydrofluoroalkane] pMDI [pressurised metered-dose inhaler] twice daily, Flutiform 100/10 microgram HFA pMDI twice daily, prednisone and placebo on the hypothalamic-pituitary-adrenal axis in adult subjects with mild to moderate asthma

Next Previous
Trial Profile

A randomized, double-blind, placebo- and active-controlled, parallel group, 6-week study to evaluate the effect of multiple doses of Flutiform [formoterol/fluticasone propionate] 250/10 microgram HFA [hydrofluoroalkane] pMDI [pressurised metered-dose inhaler] twice daily, Flutiform 100/10 microgram HFA pMDI twice daily, prednisone and placebo on the hypothalamic-pituitary-adrenal axis in adult subjects with mild to moderate asthma

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 09 Nov 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Formoterol/fluticasone propionate (Primary) ; Prednisone
  • Indications Asthma
  • Focus Pharmacodynamics
  • Sponsors SkyePharma AG

    • Most Recent Events

    • 30 Nov 2008 Status changed from active, no longer recruiting to completed, as reported on ClinicalTrials.gov.
    • 18 Aug 2008 Planned end date changed from 1 Jul 2008 to 1 Sep 2008 as reported by ClinicalTrials.gov.
    • 18 Aug 2008 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top